The role of radical prostatectomy as an initial approach for the treatment of high-risk prostate cancer

Actas urologicas españolas
J H JaunarenaC R Giudice

Abstract

The treatment of high-risk prostate cancer requires a multimodal approach to improve control of the disease. There is still no consensus as to the initial strategy of choice. The aim of this study is to review the results of radical prostatectomy as first step in management of patients with high-risk disease. A search was conducted on PubMed of English and Spanish texts. We included those studies that reported the results of radical prostatectomy in patients with high-risk prostate cancer, as well as those that compared radical prostatectomy with other treatment alternatives. The last search was conducted in November 2015. The advantages of radical prostatectomy include a better pathological analysis, more accurate staging, better local control of the disease and better follow-up and adjuvant therapy strategies. When compared with external radiation therapy plus hormonal blockade, the patients who underwent prostatectomy had greater chances of healing and longer cancer-specific survival. The patients who most benefit from this approach are younger, have fewer comorbidities and no evidence of organ metastases. The available scientific evidence to date is not without bias and confounders; however, they appear to favour radical pr...Continue Reading

References

Feb 18, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael J ZelefskyPeter T Scardino
Oct 1, 2010·Current Oncology·A Koupparis, M E Gleave
Jan 18, 2011·The Journal of Urology·Scott E EggenerAndrew J Stephenson
May 12, 2012·International Journal of Urology : Official Journal of the Japanese Urological Association·Firas AbdollahPierre I Karakiewicz
Apr 26, 2013·Journal of the National Cancer Institute·Ravi A MadanWilliam L Dahut
Apr 26, 2013·Journal of the National Cancer Institute·Richard M HoffmanDavid F Penson
Oct 12, 2013·BJU International·Bertrand TombalJacques Irani
Nov 6, 2013·Prostate Cancer and Prostatic Diseases·D SundiA E Ross
Nov 14, 2013·Prostate International·Byung Ha Chung
May 14, 2014·Nature Reviews. Urology·Christian BachAnthony Koupparis
May 21, 2014·Nature Reviews. Clinical Oncology·Albert J ChangHoward I Scher
Jun 4, 2014·CA: a Cancer Journal for Clinicians·Carol E DeSantisAhmedin Jemal
Jun 17, 2014·The Journal of Urology·Usama MahmoodKaren E Hoffman
Dec 3, 2014·Urologic Oncology·Suzanne B Stewart, Stephen A Boorjian
Dec 11, 2014·Cancer·Zachary KlaassenStephen J Freedland
Feb 25, 2015·Nature Reviews. Urology·Jahan J MohiuddinRonald C Chen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.